Hot News
GlobalFoundries: 21 billion USD from Japan for new semiconductor plants in New York!
GFS takes over the operation of two plants in New York, supported by an investment of up to 21 billion...
GameStop: Strategy Shift, Insider Purchases of Nearly $100 Million, and a 52-Week High!
GameStop reduces unprofitable stores and focuses on efficient capital allocation. In September and...
Accenture and Workday Launch Joint Program for AI Agents in Human Resources and Finance Departments!
The consulting firm Accenture and the software provider Workday are launching a joint program to help...
Danaher – NVIDIA and Autonomous AI Labs Open New Growth Opportunities
NVIDIA partnership aims to bring AI directly to laboratory devices and accelerate research processes....
Stalemate in Patent Dispute: Liquidia Reaches Settlement with United Therapeutics
Legal peace achieved: Liquidia ends all patent disputes with United Therapeutics through a global...
Record Numbers and Supply Bottlenecks: ASML Anticipates Years of AI Boom
Orders until 2030: The immense demand for AI infrastructure is prompting customers to request orders...
Applied Materials – Investor Day Reveals Billion-Dollar Potential from Agent AI
By 2030, over two percentage points market share gain and 40% operating margin. Agent AI could require...
Strategic breakthrough in court! Qualcomm resolves licensing conflicts and secures the AI age!
Jury victory against Arm: Jurors confirm breach of contract by Arm, Qualcomm secures operational freedom...
Audience Magnet Sports! Netflix secures broadcasting rights for the Football World Cup 2030 in Spain!
Exclusive Live Rights: Netflix secures broadcasting rights for all 104 matches of the FIFA World Cup...
Apple takes on Amazon and Google with $299 “HomeView” display in the smart home market!
Apple introduces the "HomeView,” a $299 display that will become the centerpiece of its push into...
Marvell: Why Microsoft's Assault on NVIDIA Could Become a Billion-Dollar Trigger for This Stock
Microsoft plans to roll out Maia on a multi-gigawatt scale by 2027 and could reportedly deploy more...
Centene: How a new "Gold Card" program aims to drive margins in the healthcare sector
Centene benefits from a strong market position in government health programs. Recently, the company...
Tower Semiconductor: Semtech Partnership Addresses the Energy Problem of AI Data Centers
Tower and Semtech contractually secure dedicated SiGe manufacturing capacities in three countries....
Accenture Acquires British Data Specialist Sagacity and Strengthens AI-Driven Customer Intelligence!
The consulting firm Accenture has acquired the British data and customer intelligence company Sagacity,...
UnitedHealth Raises Annual Forecast After Strong Third Quarter
Year-over-year earnings leap: The adjusted earnings per share climbed from $2.92 to $4.69 in the...
Attack in the Premium Segment: Alibaba Expands AI Hardware with $450 Glasses
New Hardware Generation: Alibaba presents the "Qwen Glasses N1” in Hangzhou at an entry price...
RTX in Expansion Mode! Over $30 Billion for its Missile Systems Strengthens Order Books!
Military Record Orders: RTX secures large contracts for the SM-3 IB and SM-6 missile systems to bolster...
Expansion of Computing Infrastructure! AMD Helion is Specifically Designed for AI Agents and Expands the Ecosystem!
New Rack Architecture: AMD Helion is based on OCP standards and enables flexible configurations of...
Meta Launches Another AI Model! With Muse Wonder to Personal Superintelligence!
Model Initiative: Meta releases the Muse Wonder and Muse Wonder Full model series for enhanced, autonomous...
IREN is Reported as Cloud Partner of Anthropic – Contract Yet to be Confirmed!
According to a media report, data center operator IREN has reportedly signed a multi-year AI cloud contract...
Microsoft: 40% More AI Performance per Megawatt - Maia 300 Becomes Azure's Primary Inference System
Microsoft will deploy Maia 300 not just in individual clusters, but at a multi-gigawatt scale starting...
Biogen: Immunology serves as a new growth driver - JPMorgan upgrades assessment to Overweight and price target to 300 USD!
JPMorgan raises price target to 300 USD and rates with "Overweight". Data on Felzartamab and Litifilimab...
Bristol Myers Squibb: Phase 3 Data on Cancer Drug Validate the Expansion of Precision Oncology
The company focuses on acquisitions to offset revenue declines due to expiring patents. The active...